J&J will pick up Yellow Jersey Therapeutics, a wholly-owned subsidiary of Numab Therapeutics, for $1.25 billion to acquire ...
Elopement — when a resident wanders out of a care home — is a real risk, particularly for people with dementia. But in the ...
The acquisition bid follows in the footsteps of Calliditas recently winning FDA approval for Tarpeyo, its primary ...
The agency has brought in McKay Hathaway from VML as SVP, creative and has elevated Nat Resende to ECD in Chicago.
James Sabry, global head at Roche Pharma Partnering, is moving on from the Swiss pharma giant. Roche announced Monday that ...
Precision Value & Health, a network that housed nine agencies specializing in access work, has rebranded as Precision AQ. In ...
In the bustling New York City landscape — where choices are as diverse as the people who live there — the Hospital for ...
Caring for older adults with dementia is stressful, especially when they become physically or verbally aggressive, wander ...
Campaign explores how Asian brands are maximising ad spend at the mega sporting event, the keys to a winning marketing ...
Cannabis companies welcomed a recent proposal by the Department of Justice to reclassify marijuana as a Schedule III drug.
Increasingly, women’s health has been the subject of more campaigns, commercials and marketing initiatives. However, the best ...
Healthcare and medicine illustration concept shows a couple senior adult get advice from the doctor about how to take care ...